Devika Bose

Senior Research Services Professional

University of Colorado Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Tissue Engineering Tissue Engineering professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Devika Bose is a Senior Research Services Professional at the University of Colorado Anschutz Medical Campus Cancer Center in the United States. Her research areas include induced pluripotent stem cell (iPSC) applications in retinal therapy, macrophage differentiation, and disease modeling related to retinal disorders. She has contributed significantly to the understanding of lipid profile changes in retinal conditions and potential therapeutic targets for age-related macular degeneration.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Davide Ortolan

National Eye Institute

UNITED STATES

View details

Deborah A. Ferrington

University of Minnesota Twin Cities

UNITED STATES

View details

Kathleen Boesze‐Battaglia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Devika Bose

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Considerations for Developing an Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) Replacement Therapy

Differentiation of monocytes and polarized M1/M2 macrophages from human induced pluripotent stem cells

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD

Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration

LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium

Retina and RPE lipid profile changes linked with ABCA4 associated Stargardt's maculopathy

Cell-autonomous lipid-handling defects in Stargardt iPSC-derived retinal pigment epithelium cells

In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium

Triphasic developmentally guided protocol to generate retinal pigment epithelium from induced pluripotent stem cells

AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration

Collaborators (3)

Davide Ortolan

Deborah A. Ferrington

Kathleen Boesze‐Battaglia

Make your next move.